The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms
NCT ID: NCT02495311
Last Updated: 2023-09-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2014-11-15
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Association Between Ovarian Endometrioma and Lower Urinary Tract Symptoms
NCT02623244
Lower Urinary Tract Infection (UTI) Evaluation in Women With Uterine Leiomyomata
NCT01123603
Accuracy of Endomyometrial Biopsy in Diagnosis of Adenomyosis
NCT05505656
Histopathological Diagnosis of Adenomyosis
NCT02340533
Assessing Ultrasonographic Severity of Adenomyosis
NCT06117410
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women with uterine myoma
Women with uterine myoma
myomectomy or adenomyomectomy
Women with adenomyosis
Women with adenomyosis
myomectomy or adenomyomectomy
Women without uterine myoma or adenomyosis
Control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
myomectomy or adenomyomectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Myoma: women with \>3 cm uterine myoma
3. Adenomyosis: women with uterus having several dark area (lacunar areas) in one uterine wall or thickening uterine wall
\<The control group\>
1. \>20 years old.
2. Women without myoma or adenomyosis
\<Both groups\>
Exclusion Criteria
2. Previous surgery for the bladder or urethra.
3. History of urinary tract stones or tumors.
20 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Far Eastern Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sheng-Mou Hsiao
Chief, Department of Obstetrics & Gynecology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sheng-Mou Hsiao, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Obstetrics & Gynecology, Far Eastern Memorial Hospital, Banqiao, New Taipei, Taiwan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Far-Eastern Memorial Hospital
Banqiao District, New Taipei, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
103129-F
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.